Department of Family Medicine, HaEmek Medical Center, Afula, Israel.
Ann Fam Med. 2010 Jan-Feb;8(1):25-32. doi: 10.1370/afm.1071.
The purpose of this study was to evaluate differences in the management of cardiovascular disease (CVD) risk factors based upon the sex of the patient and physician and their interaction in primary care practice.
We evaluated CVD risk factor management in 4,195 patients cared for by 39 male and 16 female primary care physicians in 30 practices in southeastern New England.
Many of the sex-based differences in CVD risk factor management on crude analysis are lost once adjusted for confounding factors found at the level of the patient, physician, and practice. In multilevel adjusted analyses, styles of CVD risk factor management differed by the sex of the physician, with more female physicians documenting diet and weight loss counseling for hypertension (odds ratio [OR] = 2.22; 95% confidence interval [CI], 1.12-4.40) and obesity (OR = 2.14; 95% CI, 1.30-3.51) and more physical activity counseling for obesity (OR = 2.03; 95% CI, 1.30-3.18) and diabetes (OR = 6.55; 95% CI, 2.01-21.33). Diabetes management differed by the sex of the patient, with fewer women receiving glucose-lowering medications (OR = 0.49; 95% CI, 0.25-0.94), angiotensin-converting enzyme inhibitor therapy (OR = 0.39; 95% CI, 0.22-0.72), and aspirin prophylaxis (OR = 0.30; 95% CI, 0.15-0.58).
Quality of care as measured by patients meeting CVD risk factors treatment goals was similar regardless of the sex of the patient or physician. Selected differences were found in the style of CVD risk factor management by sex of physician and patient.
本研究旨在评估基于患者和医生的性别以及他们在初级保健实践中的相互作用,对心血管疾病(CVD)风险因素管理的差异。
我们评估了 39 名男性和 16 名女性初级保健医生在新英格兰东南部 30 个实践中照顾的 4195 名患者的 CVD 风险因素管理情况。
在对混杂因素进行调整后,许多基于性别的 CVD 风险因素管理差异在粗分析中消失了,这些混杂因素存在于患者、医生和实践层面。在多层次调整分析中,CVD 风险因素管理风格因医生的性别而异,更多的女性医生记录高血压(比值比[OR] = 2.22;95%置信区间[CI],1.12-4.40)和肥胖症(OR = 2.14;95% CI,1.30-3.51)的饮食和减肥咨询,以及肥胖症(OR = 2.03;95% CI,1.30-3.18)和糖尿病(OR = 6.55;95% CI,2.01-21.33)的更多体力活动咨询。糖尿病管理因患者的性别而异,接受降血糖药物治疗的女性更少(OR = 0.49;95% CI,0.25-0.94),血管紧张素转换酶抑制剂治疗(OR = 0.39;95% CI,0.22-0.72),以及阿司匹林预防(OR = 0.30;95% CI,0.15-0.58)。
无论患者或医生的性别如何,以患者达到 CVD 风险因素治疗目标的方式来衡量,护理质量都是相似的。根据医生和患者的性别,发现了 CVD 风险因素管理风格的某些差异。